Interleukin regulation of asymmetric antibody synthesized by isolated placental B cells

American Journal of Reproductive Immunology

Volumn 48, Issue 4, 2002, Pages 275-282

  Canellada, A ^a,c   Farber A ^b   Zenclussen, A C ^a   Gentile, T ^a   Dokmetjian, J ^a   Keil, A ^b   Blois, S ^a   Miranda, S ^a   Berod, L ^a   Gutierrez G ^a   Markert, U R ^b   Margni, R A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c NONE   (Argentina)

Author keywords

B lymphocytes; Blocking antibodies; Cytokines; Placenta

Indexed keywords

CD40 ANTIGEN; CONCANAVALIN A; CYTOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; ASYMMETRIC SYNTHESIS; B LYMPHOCYTE; CELL ISOLATION; CELL LINE; CELL SECRETION; CELL SPECIFICITY; CELL STIMULATION; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST CULTURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SUPERNATANT; TH2 CELL; UMBILICAL CORD BLOOD;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN G; INTERLEUKINS; MICE; PLACENTA;

EID: 18544377291     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0897.2002.01125.x     Document Type: Article

References (47)

1. Wegmann TG, Lin H, Guilbert L, Mossmann TH: Bidirectional cytokines interactions in the materno-fetal relationship: successful allopregnancy is a Th2 phenomenon. Immunol Today 1993; 14:353-355.
2. Hunt JS, Roby KF: Implantation factors. Clin Obstet Gynecol 1994; 37:635-645.
3. Savino W, Dardenne M: Immune-neuroendocrine interactions. Immunol Today 1995; 16:318-322.
4. Simon C, Frances A, Pellicer A, Polan ML: Cytokines in implantation. Semin Reprod Endocrinol 1995; 13:142-151.
5. Nishino E, Matsuzaki N, Masuhiro K, Kameda T, Taniguchi T, Takagi T, Saji F, Tanizawa O: Trophoblast derived IL-6 regulates hCG release through IL-6 receptor on human trophoblasts. J Clin Endocrinol Metab 1990; 74:184-190.
6. De Moraes Pinto MI, Vince GS, Flanagan BF, Hart CA, Johnson PM: Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes. Immunology 1996; 90:87-94.
7. Roth I, Corry DB, Locksley RM, Abrams JS, Littpn MJ, Fisher SJ: Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin-10. J Exp Med 1996; 184:539-548.
8. Saito S: Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47:87-103.
9. Mowbray JF, Underwood JL: Immunology of abortion. Clin Exp Immunol 1985; 60:1-7.
10. Innes A, Cunningham C, Power DA, Catto GRD: Fetus as an allograft: noncytotoxic maternal antibodies to HLA-linked paternal antigens. Am J Reprod Immunol 1989; 19:146-150.
11. Malan Borel I, Gentile T, Angelucci J, Pividori J, Margni R: IgG asymmetric molecules with anti-paternal activity isolated from sera and placenta of pregnant human. J Reprod Immunol 1991; 20:129-140.
12. Mowbray J, Jalali R, Chaouat G, Clark DA, Underwood J, Allen WR, Mathias S: Maternal response to paternal trophoblast antigens. Am J Reprod Immunol 1997; 37:421-426.
13. Jalali GR, Rezai A, Underwood JL, Mowbray JF, Surridge SH, Allen WR, Matthias S: An 80-kDa syncytiotrophoblast alloantigen bound to maternal alloantibody in term placenta. Am J Reprod Immunol 1995; 33:213-220.
14. Jalali GR, Arck P, Surridge S, Markert U, Chaouat G, Clark DA, Underwood JL, Mowbray JF: Immunosuppressive properties of monoclonal antibodies and human polyclonal alloantibodies to the R80K protein of trophoblast. Am J Reprod Immunol 1996; 36:129-134.
15. Labeta M, Margin R, Leoni J, Binaghi R: Structure of asymmetric non-precipitating antibodies. Presence of a carbohydrate residue in only one Fab region of the molecule. Immunology 1986; 57:314-317.
16. Leoni J, Labeta M, Margni RA: The asymmetric IgG non-precipitating antibody. Localization of the oligosaccharide involved by concanavalin A interaction. Mol Immunol 1986; 23:1397-1400.
17. Margni RA, Binaghi RA: Non-precipitating asymmetric antibodies. Ann Rev Immunol 1988; 6:535-554.
18. Morelli L, Leoni J, Fossati C, Margni R: Symmetric and asymmetric IgG antibodies are synthesized by the same cellular clone. Mol Immunol 1989; 26:789-792.
19. Gentile T, Malan Borel I, Angelucci J, Miranda S, Margni R: Prefferential synthesis of asymmetric antibodies in rat immunized with paternal particulate antigens. Effects on pregnancy. J Reprod Immunol 1992; 22:173-183.
20. Gentile T, Llambias P, Dokmetjian J, Margni RA: Effect of pregnancy and placental factors on the quality of humoral immune response. Immunol Lett 1998; 62:151-157.
21. Margni RA, Malan Borel I: Role of asymmetric antibodies in fetal maintenance. Curr Trends Immunol 1999; 2:153-163.
22. Gutierrez G, Malan Borel I, Margni RA: The placental regulatory factor involved in the asymmetric IgG antibody synthesis responds to IL-6 features. J Reprod Immunol 2001; 49:21-32.
23. Buttler J, Spradling J, Suter M, Dierks S, Heyermann H, Peterman J: The immunochemistry of sandwich ELISA-I. The binding characteristics of immunoglobulins to monoclonal and polyclonal antibodies adsorbed on plastic and their detection by symmetric and asymmetric antibody-enzyme conjugates. Mol Immunol 1986; 23:971-982.
24. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324:73-76.
25. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE: B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 1986; 136:4538-4541.
26. Vitetta ES, Ohara J, Myers CD, Layton JE, Krammer PH, Paul WE: Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med 1985; 162:1726-1731.
27. Niess JH, Bär C, Nuske K, Vogelsang H, Schlenvoigt G, Heusser C, Junker U, Zwacka G, Markert UR: Immunglobulin-Klassen-Switch im CD40-B-Zell-Kultursystem durch die Interleukine IL-4, IL-6, IL-10, IL-11 und IL-13. Allergologie 2000; 23:116-121.
28. Neben S, Turner K: The biology of interleukin-11. Stem Cells 1993; 11:156-162.
29. Kobayashi S, Teramura M, Oshimi K, Mizoguchi H: Interleukin-11. Leuk Lymphoma 1994; 15:45-49.
30. Walmsley M, Buttler DM, Marinova-Mutafchieva L, Feldmann M: An anti-inflammatory role for interleukin-11 in established murine collagen-induced arthritis. Immunology 1998; 95:31-37.
31. Li Y, Simons ER, HayGlass KT: Environmental antigen-induced IL-13 responses are elevated among subjects with allergic rhinitis, are independent of IL-4 and are inhibited by endogenous IFN-γ synthesis. J Immunol 1998; 161:7007-7014.
32. + Th0 and Th2 T cell clones and EBV-transformed B-cells. Int Immunol 1995; 7:1405-1416.
33. Ochensberger B, Daepp GC, Rihs S, Dahinden CA: Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and independent activation. Blood 1996; 88:3028-3037.
34. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J: Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175:671-682.
35. Pos O, Moshage HJ, Yap SH, Snieders JP, Aarden LA, van Gool J, Boers W, Brugman AM, van Dijk W: Effects of monocytic products, recombinant interleukin-1, and recombinant interleukin-6 on glycosylation of alpha 1-acid glycoprotein: studies with primary human hepatocyte cultures and rats. Inflammation 1989; 13:415-427.
36. Mackiewicz A, Rose-John S, Schooltink H, Laciak M, Gorny A, Heinrich PC: Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of alpha 1-protease inhibitor secreted by HepG2 cells. FEBS Lett 1992; 306:257-261.
37. Chintalacharuvu SR, Emancipator SN: The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J Immunol 1997; 159:2327-2333.
38. Chintalacharuvu SR, Emancipator SN: Differential glycosylation of two glycoproteins synthesized by murine B cells in response to IL-4 plus IL-5. Cytokine 2000; 12:1182-1188.
39. Wang Y, Fuller GM: Biosynthetic and glycosylation events of the IL-6 receptor beta-subunit, gp130. J Cell Biochem 1995; 57:610-618.
40. + T cells. J Exp Med 1997; 185:461-469.
41. Piccinni MP, Guidizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi S, Maggi E: Progesterone favors the development of human T helper cells producing Th2 type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155:128-133.
42. Lim KJH, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID: Profile of cytokine mRNA expression in periimplantation human endometrium. Mol Hum Reprod 1998; 4:77-81.
43. Keleman K, Bognar I, Paal M, Szekeres-Bartho J: A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol 1996; 167:129-134.
44. Chaouat G: Cytokine networks at the feto-maternal interface: are the existing paradigms still valid? Am J Reprod Immunol 2001; 46:25 (Abstract MS2-1).
45. Croy BA: Where now for the Th1/Th2 paradigm of the gestational uterus? J Reprod Immunol 2001; 51:1-2.
46. Arck PC, Zenclussen AC, Fest S, Sehmsdorf US, Klapp BF: Challenging the Th1/Th2 dichotomy. Am J Reprod Immunol 2001; 45:358 (Abstract P11).
47. Margni RA, Zenclussen AC: During pregnancy, in the context of a Th2-type cytokine profile, IL-6 levels might condition the quality of the synthesized antibodies. Am J Reprod Immunol 2000; 44:22-29.